Delivery of sorafenib by myofibroblast-targeted nanoparticles for the treatment of renal fibrosis

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen et al. · The Lancet Oncology · 2008 · 5.8K citations

Medicine, Oncology, Pharmacotherapy +11

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine · 2014 · 3.9K citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Fate Tracing Reveals the Pericyte and Not Epithelial Origin of Myofibroblasts in Kidney Fibrosis

Benjamin D. Humphreys, Shuei‐Liong Lin, Akio Kobayashi et al. · American Journal Of Pathology · 2009 · 1.4K citations · Full text

Medicine, Cell Biology, Pathology +16

Origin and function of myofibroblasts in kidney fibrosis

Valerie S. LeBleu, Gangadhar Taduri, Joyce T. O’Connell et al. · Nature Medicine · 2013 · 1.2K citations · Full text

Medicine, Cell Biology, Nephrology +12

Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy

Robert L. Chevalier, Michael S. Forbes, Barbara A. Thornhill · Kidney International · 2009 · 1K citations

Medicine, Nephrology, Urology +15